AzTrials
AzTrials

DementiaLENDNCT07757178

Lived Experience Narratives in Dementia

A study testing Online LEND Intervention in people with Dementia and Neuro-Degenerative Disease, run by University of Nottingham at 2 sites in United Kingdom.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The Lived Experience Narratives in Dementia (LEND) research programme involves five work packages (WP). WP1 explores how people living with dementia use narratives and how narratives can impact them. Findings will support the development of LEND theory. Read more about this study

Who is it for?
Ages 18 to 99 yearsHealthy volunteers can take part
What is being tested?
Online LEND Intervention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
2 sitesUnited Kingdom
Study dates
17 Nov 2025to Jul 2029
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 99 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

General Inclusion Criteria (apply across WP1-WP3)

  • Adults aged 18+.
  • Able to give informed consent and participate meaningfully in the required tasks.
  • Adequate communication ability in the required study language

General Exclusion Criteria (apply across WP1-3)

  • Living in a hospital or healthcare institution at the time of the study.
  • Refusal or inability to provide informed consent, or lack of capacity to consent.
  • Inability to comprehend participant information or communicate meaningfully

Trial locations and contacts

2 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Linda E O'Raw, PhD contact

07791598280

linda.o'raw@nottingham.ac.uk

Mark Howells contact

mark.howells@nottshc.nhs.uk

United Kingdom2 sites, 2 recruiting
  • Mental Health & Clinical Neurosciences, Institute of Mental Health

    Nottingham, England, NG7 2TU

    Martin Orrell, Director of IMH & LEND CI, 0115 823 1294, M.Orrell@nottingham.ac.uk

    Linda O'Raw, LEND Programme Manager, 07791598280, linda.o'raw@nottingham.ac.uk

    Recruiting
  • Nottinghamshire Healthcare NHS Foundation , Highbury Hospital

    Nottingham, NG6 9DR

    Mark Howells, Sponsor, 0115 969 1300, mark.howells@nottshc.nhs.uk

    Recruiting

Other trials in United Kingdom

About this study

Official title: Improving the Quality of Life for People Living With Dementia and Carers: The Design and Development of a Dementia Specific Online Narrative-Based Intervention With a Feasibility Study

The Lived Experience Narratives in Dementia (LEND) research programme involves five work packages (WP). WP1 explores how people living with dementia use narratives and how narratives can impact them. Findings will support the development of LEND theory. WP 2-3 focus on developing the digital Online LEND Intervention, assessing its usability and acceptability, and conducting a feasibility study within NHS memory assessment and community services. Activities across the first three WPs include interviews, focus groups, user-testing sessions, engagement evaluation interviews, and a two-arm randomised feasibility trial using a range of outcome measures. Findings from this stage will inform refinement of the intervention and determine the feasibility of progressing to a future randomised controlled trial (RCT) of the Online LEND Intervention. WP4 is the Online LEND Intervention two-arm RCT. WP5 involves dissemination. The protocol for WP4 and 5 have not yet been developed and rely on results from WP1-3.

Read the detailed description

Study Overview The Lived Experience Narratives in Dementia (LEND) Programme is a five-year NIHR-funded research programme designed to develop, optimise, and evaluate a novel digital intervention that delivers personalised lived-experience narratives to people living with dementia and their carers. The ultimate goal is to improve wellbeing and quality of life by providing accessible, relatable, and culturally diverse narratives that promote hope, self-efficacy, independence, and emotional support.

Packages (WP) 1-3, includes theory development (WP1), intervention development (WP2), and a randomised controlled feasibility study with long-term follow-up interviews (WP3).

LEND prioritises inclusion of under-served communities, including Black and South Asian groups, LGBT+ communities, people with young-onset dementia, and people with rarer dementias (see LEND WP1-3 Protocol v1.0 CLEAN).

WORK PACKAGE 1: Development of LEND Theory WP1 develops the theoretical foundations that shape the design and content of the LEND digital intervention. It consists of five interconnected sub-work packages, each addressing a different element of user experience, narrative relevance, and contextual factors affecting engagement.

WP1.1: Online or Paper Survey (WP1.1O / WP1.1P) Purpose: To understand how people living with dementia and carers use social media, technology, and online resources over time.

Design: A continuous cross-sectional survey, recruiting ≥300 participants per year over five years (minimum n=1,500 total) LEND WP1-3 Protocol v1.0 CLEAN

Focus:

  • Patterns of online behaviour
  • Barriers and facilitators to digital engagement
  • Types of narratives accessed, preferred formats, and comfort levels with online content

WP1.2: Semi-Structured Interviews Purpose: To explore how lived-experience narratives may benefit people living with dementia and carers, informing LEND theory.

Sample: n=30 (15 people with dementia; 15 carers) LEND WP1-3 Protocol v1.0 CLEAN

Focus:

  • Perceived use and impact of narratives
  • Digital literacy, accessibility, and digital poverty

WP1.3a: Narrative Impact Validation Purpose: To test how participants engage with up to five lived-experience narratives selected from an initial pool of ~30 narratives, including those from ethnic minority and under-served groups.

Sample: n=40 (20 people with dementia; 20 carers) LEND WP1-3 Protocol v1.0 CLEAN

Focus:

  • Emotional and cognitive responses to narratives
  • Comprehension, resonance, and perceived relevance
  • The development of criteria
  • Safety considerations (e.g., triggering material, content warnings)

WP1.3b: Narrative Rating Purpose: To develop a categorisation framework for dementia narratives based on user ratings and feedback.

Sample: Repeat measures from WP1.3a.

Focus:

  • Narrative qualities (tone, genre, turning points, themes)
  • Degree of helpfulness, clarity, relatability
  • Score or rate different types of narrative
  • User preferences to inform algorithmic recommendations

WP1.4: Focus Groups Purpose: Conducted in collaboration with the Centre for Ethnic Health Research, WP1.4 prioritises inclusion of Black, South Asian, and other under-served communities.

Sample: Four focus groups (n=40 total) LEND WP1-3 Protocol v1.0 CLEAN

Focus:

  • Cultural perceptions of dementia
  • Barriers to accessing support and digital interventions
  • Relevance, acceptability, and cultural safety of narratives

WP1.5: Discrete Choice Experiment (DCE) Purpose: To determine which narrative features are most valued by people with dementia, carers, and the general public.

Sample:

  • n=10 people with dementia
  • n=10 carers
  • n=10 general public LEND WP1-3 Protocol v1.0 CLEAN

Focus:

  • Trade-offs between different narrative types
  • Preferences relating to narrator characteristics, narrative tone, format, and content
  • Input directly informing later intervention design

WORK PACKAGE 2: Development of LEND Intervention WP2 focuses on building the digital intervention through iterative, user-centred development.

WP2.3: Development of the LEND Digital Intervention WP2.3 is a multi-phase iterative development process consisting of workshops, prototype development, usability testing, accessibility refinement, and preparation for feasibility evaluation.

Phase 1: Co-production Workshops (Months 10-12)

Using LEAP (Lived Experience Advisory Panel) members and developers:

  • Identify essential features of the LEND Portal and Online LEND Intervention
  • Determine accessibility requirements and inclusive design priorities Phase 2: First Working Version (Months 12-14)
  • Build initial prototype of the LEND web application
  • Conduct first stage of usability testing with n=20 participants (10 carers, 10 people with dementia)
  • Develop expert rules for relevance-based narrative retrieval Phase 3: Second Working Version \& Testing (Months 14-18)
  • Refine interface based on feedback
  • Achieve AA-level accessibility compliance (WCAG \& EN 301 549)
  • Conduct second usability testing cycle with n=20 (balanced sample) Phase 4: Third Working Version (Months 18-36)
  • Produce pre-feasibility version of intervention
  • Conduct in-vivo user testing
  • Recruit from earlier phases to conduct extended testing

Key Features of Intervention (developed across WP2.3):

  • Web-based LEND Portal (registration, consent, outcome measures)
  • Machine-learning narrative recommender
  • Narrative filtering and content warnings
  • Ability to rate, block, or bookmark narratives
  • Optional LEND eBooklet for digital inclusion (low-tech video player) All narratives used are categorised using the INCRESE-D system developed in WP2.1 and curated into the LEND Collection (WP2.2).

WORK PACKAGE 3: Feasibility Study and Long-Term Impact WP3 evaluates feasibility, acceptability, and preliminary signals of impact in preparation for a full-scale RCT.

WP3.1: Randomised Controlled Feasibility Study

Design:

  • Parallel-group RCT with 1:1 randomisation
  • Intervention (Online LEND Intervention) vs. Treatment as Usual (TAU)
  • Stratified by co-resident carer status
  • Remote computerised randomisation via Bangor Clinical Trials Unit
  • Analysts blinded to allocation Sample: n=60
  • 30 people with dementia
  • 30 carers Duration: 6-month follow-up period

Outcome Measures (all self-report via LEND Portal):

Primary outcomes include:

  • QoL-AD (PWoD only)
  • SWEMWBS (both groups)

Secondary outcomes include:

  • EID-Q, RSES, GSES, CSES, Zarit Burden, EQ-5D-5L, ICECAP-O, Adult Hope Scale, CSRI

Feasibility Outcomes:

  • Recruitment rates and retention
  • Adherence and engagement with intervention (time spent, narratives accessed)
  • Acceptability and suitability of intervention in real-world contexts
  • Data completeness and technical viability of digital data collection

WP3.2: Long-Term Impact Interviews Purpose: To evaluate longer-term influence of the LEND intervention among those who received it in WP3.1.

Sample: n=20

  • 10 people with dementia
  • 10 carers

Timing:

  • 12 months post-randomisation
  • 18 months post-randomisation

Focus:

  • Sustained changes in wellbeing, confidence, independence, and support
  • Usability, acceptability, suitability over longer durations
  • Experiences with platform features and narrative engagement
  • Identification of risks, barriers, or unintended consequences Interviews are recorded, transcribed, and linked to participants' engagement and demographic data using a pseudonymised UID system

Integrated Purpose of WP1-3

Collectively, these work packages:

  • Establish the theoretical foundation (WP1)
  • Develop a user-centred and accessible digital intervention (WP2)
  • Evaluate feasibility, acceptability, and preliminary outcomes required for a future fully powered clinical trial (WP3) This integrated, iterative design follows the MRC Framework for Developing and Evaluating Complex Interventions (2021) and aligns with NICE digital technology evidence standards.

WP4 and WP5 will be determined following the evaluation of WP1-3.

Being tested
Online LEND Intervention
Medical subject headings
Dementia, Alzheimer Disease, Caregiver Burden

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Online LEND InterventionBehavioural

    The Online LEND Intervention is a web-based platform that provides personalised lived-experience narratives for people with dementia and their carers. It aims to support wellbeing, confidence, and self-efficacy by offering relatable stories from others with similar experiences. The final design is still in development but is expected to include personalised recommendations, simplified navigation, adjustable text, audio playback, captioning, and content warnings. Users will be able to bookmark, rate, or hide stories and access the intervention independently at home over a 4 to 6-week period. The platform will be accessed via the secure LEND Portal, where participants also complete study measures. LEND does not provide clinical advice; it offers supportive, ethically reviewed narratives to promote connection and empowerment.

Study groups in NCT07757178
Study groupRoleWhat they receive
Online LEND InterventionExperimentalParticipants in WP3, the feasibility trial, are allocated to this arm receive access to the LEND digital intervention. The intervention consists of a web-based platform that provides personalised lived-experience narratives curated for people with dementia and their family carers. Content includes written, audio, and video narratives covering themes such as coping strategies, identity, emotions, daily living, social relationships, and adjusting to diagnosis. Participants are able to browse and select narratives; receive recommendations based on preferences; bookmark or rate content; and use accessibility features designed to support cognitive needs, including simplified navigation, adjustable text, and audio playback. The intervention is used independently at home for 4 to 6 weeks, with no minimum usage requirement. Participants also complete baseline and follow-up outcome measures through the integrated LEND Portal prior to randomisation.
Receives: Behavioral: Online LEND Intervention
Treatment as UsualNo interventionParticipants randomised to this arm continue to receive their standard care and support as normally provided. This may include by NHS Memory Assessment Services, community mental health teams, primary care, and other relevant voluntary-sector and non voluntary-sector organisations. They do not receive access to the Online LEND Intervention during the feasibility study period. Prior to randomisation, participants complete the same baseline outcome measures. Access to the LEND portal, but not the Online LEND Intervention, is continued as follow-up outcome measures are required after 6 months period, paralleling the intervention arm.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Quality of Life (QoL-AD)

    The Quality of Life in Alzheimer's Disease (QoL-AD) scale is a validated measure captures wellbeing across multiple domains including mood, relationships, daily activities, memory, and overall life satisfaction. The feasibility study will assess completeness of data, variability, and acceptability of QoL-AD as the primary endpoint for a future definitive RCT.

    Measured: Baseline and Six Months

  2. Mental Wellbeing (SWEMWBS)

    The Short Warwick-Edinburgh Mental Wellbeing Scale (SWEMWBS). This seven-item scale assesses emotional functioning, optimism, and psychological wellbeing. The feasibility study will evaluate suitability, recruitment, retention, and response characteristics of SWEMWBS as the primary carer outcome for the full trial.

    Measured: Baseline and Six Months

Secondary outcomes (2)
  1. Engagement and Independence in Dementia Questionnaire (EID-Q)

    For people with dementia only. Assesses engagement in meaningful activities, independence, autonomy, and perceived capabilities in daily life.

    Measured: Baseline and Six Months

  2. Rosenberg Self-Esteem Scale - Brief Version (RSES)

    For both people with dementia and family carers. Measure of global self-esteem and self-worth.

    Measured: Baseline and Six Months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Aug 2026
  2. Study start17 Nov 2025
  3. Primary completionMar 2029 (estimated)
  4. Study completionJul 2029 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
In WP3, this study uses a two-arm parallel-group randomised feasibility design in which participants are allocated 1:1 to either the Online LEND Intervention or a Treatment-as-Usual (TAU) control group. The purpose of the design is not to test clinical effectiveness but to evaluate the feasibility and acceptability of trial procedures, including recruitment, randomisation, retention, data collection, participant engagement, and outcome measure completion. Randomisation is stratified by whether the person with dementia has a co-resident carer, and allocation is performed using a secure, automated computerised system managed by the Bangor Clinical Trials Unit. Analysts and outcome assessors are blinded to group allocation. The results of this feasibility randomised trial will be used to inform the design and delivery of a future fully powered randomised controlled trial.
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07757178
Sponsor's protocol ID
IRAS351969
Other IDs
NIHR206255
Acronym
LEND
Status last verified
Nov 2025
First submitted
28 Jul 2026
Last updated
11 Aug 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Only anonymised data will be shared for the purposes of analysis and interpretation.

Questions about this trial

What is this clinical trial studying?

A study testing Online LEND Intervention in people with Dementia and Neuro-Degenerative Disease, run by University of Nottingham at 2 sites in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 11 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Linda E O'Raw, PhD (07791598280, linda.o'raw@nottingham.ac.uk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Quality of Life (QoL-AD) (time frame: Baseline and Six Months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Aug 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in